FIELD: medicine.
SUBSTANCE: invention relates to a new zinc complex of gamma-L-glutamylhistamine of formula
.
Also disclosed are a method of producing and using said zinc complex and a pharmaceutical composition containing the complex.
EFFECT: disclosed zinc complex according to the invention promotes recovery of a barrier function of epithelial tissue, suppresses aberrant activity of immune system cells and is able to inhibit glutaminyl cyclase.
11 cl, 6 dwg, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW INHIBITOR OF GLUTAMINYL CYCLASE AND ITS USE FOR TREATMENT OF LUNG AND RESPIRATORY DISEASES | 2017 |
|
RU2662559C1 |
| NEW GLUTAMINE CYCLASE INHIBITOR AND ITS APPLICATION | 2018 |
|
RU2791703C2 |
| NEW INHIBITOR OF GLUTAMINYL CYCLASE AND ITS USE | 2017 |
|
RU2665633C1 |
| ANTI-INFLAMMATORY AND ANTI-ITCHING CREAM FOR TREATMENT OF DERMATOLOGICAL DISEASE | 2002 |
|
RU2233152C1 |
| EXTERNAL THERAPEUTIC AGENT FOR PATIENTS SUFFERING ATOPIC DERMATITIS | 2012 |
|
RU2496476C1 |
| USE OF PREPARATION LAENNEK FOR TREATING A DISEASE, ASSOCIATED WITH IMPAIRED IMMUNITY, WHICH IS A CHRONIC RECURRENT HERPES, ATOPIC DERMATITIS OR PSORIASIS | 2015 |
|
RU2599038C1 |
| LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
| PHARMACEUTICAL COMPOSITIONS FOR INHIBITING INFLAMMATORY CYTOKINES | 2019 |
|
RU2816868C2 |
| METHOD OF TREATING PSORIASIS VULGARIS | 2012 |
|
RU2476228C1 |
